Skip to content

TANITA BIA Validation Study

TANITA BIA Validation Study - TANITA BIA Validation Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048570
Enrollment
30
Registered
2022-08-03
Start date
2022-08-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

APO PLUS STATION CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Japanese men and women from the ages of 20 and older to below the age of 65 at the time of consent acquisition. 2.Subjects have been fully informed of the purpose and content of the study and who have signed a consent form prior to the start of the study. 3.Subjects are judged by the study investigator to be safe to participate in the study

Exclusion criteria

Exclusion criteria: 1.Subjects undergoing treatment for or with a history of malignancy, heart failure, or myocardial infarction 2.Subjects with implanted pacemakers or implantable cardioverter defibrillators 3.Those under treatment for arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, and other chronic diseases 4.Pharmaceuticals (including herb.al medicines) ?Persons who regularly use dietary supplements 5.Pregnant, lactating, or intending to become pregnant during the study period 6.Subjects with cochlear implants or cochlear implants 7.Subjects with dental implants 8.A person who is performing nail 9.Other persons who are determined to be unsuitable based on a pre-measurement interview 10.Other subjects deemed inappropriate for this study by the investigator

Design outcomes

Primary

MeasureTime frame
Comparison of visceral fat area data, body fat percentage data, muscle mass data, and bone mass data from mutual medical devices

Countries

Japan

Contacts

Public ContactMisaki Sakata

APO PLUS STATION CO., LTD CRO Business division

food-contact@apoplus.co.jp03-6386-8809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026